ArticlePloS one2026

Systems pharmacology reveals type I interferon and myeloid-like B cell reprogramming as candidate druggable axes in antiphospholipid syndrome.

Bin Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.